Please enable JavaScript to continue using this application.

Compare $MDLN vs $SOLV | Chartloom

Compare

$MDLN vs $SOLV

Medline Inc · Solventum Corp

MDLN

Medline Inc

SOLV

Solventum Corp

Compare $MDLN vs $SOLV

Comparing Medline Inc and Solventum Corp

MDLNMedline Inc

SOLVSolventum Corp

MDLNMedline Inc

Market cap

$47.63B

P/E (TTM)

44.92x

Forward P/E (NTM)

24.12x

Forward P/S (NTM)

1.44x

Rev growth (TTM)

—

YTD performance

-10.7%

52W performance

-11.6%

FCF yield

3.2%

SOLVSolventum Corp

Market cap

$15.12B

P/E (TTM)

10.55x

Forward P/E (NTM)

12.69x

Forward P/S (NTM)

1.77x

Rev growth (TTM)

-0.9%

YTD performance

10.5%

52W performance

20.5%

FCF yield

-0.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MDLN

SOLV

Detailed metrics comparison

MDLN

Medline Inc

SOLV

Solventum Corp

Market Cap

MDLN$47.63B

SOLV$15.12B

Enterprise Value

MDLN$57.88B

SOLV$20.00B

Price

MDLN$36.26

SOLV$87.29

P/E Ratio

MDLN44.92x

SOLV10.55x

P/S Ratio

MDLN1.59x

SOLV1.82x

EV/Sales

MDLN1.93x

SOLV2.41x

EV/EBITDA

MDLN17.66x

SOLV18.02x

P/B Ratio

MDLN4.05x

SOLV3.12x

P/FCF Ratio

MDLN30.81x

SOLVN/A

EV/FCF

MDLN37.44x

SOLV-172.41x

PEG Ratio

MDLN3.82x

SOLV0.04x

Forward P/E (NTM)

MDLN24.12x

SOLV12.69x

Forward P/S (NTM)

MDLN1.44x

SOLV1.77x

Revenue (TTM)

MDLN$29.94B

SOLV$8.31B

Revenue Growth (YoY)

MDLNN/A

SOLV-0.9%

Forward Rev Growth

MDLN7.8%

SOLV3.5%

Gross Margin (TTM)

MDLN26.2%

SOLV54.8%

Operating Margin (TTM)

MDLN6.0%

SOLV23.9%

EBITDA Margin (TTM)

MDLN10.9%

SOLV13.4%

Net Margin (TTM)

MDLN2.3%

SOLV17.3%

FCF Margin (TTM)

MDLN5.2%

SOLV-1.4%

Net Income (TTM)

MDLN$695M

SOLV$1.43B

FCF (TTM)

MDLN$1.55B

SOLV$-116M

EPS (TTM)

MDLN$0.81

SOLV$8.27

ROE (TTM)

MDLN5.5%

SOLV29.0%

ROA (TTM)

MDLN1.8%

SOLV10.1%

ROIC (TTM)

MDLN2.6%

SOLV14.2%

Cash

MDLN$2.33B

SOLV$403M

Debt

MDLN$12.58B

SOLV$5.29B

Net Cash/Debt

MDLN$-10.25B

SOLV$-4.88B

Current Ratio (TTM)

MDLN4.33x

SOLV1.02x

Quick Ratio (TTM)

MDLN2.61x

SOLV0.70x

Debt/Equity (TTM)

MDLN1.09x

SOLV1.10x

Debt/Assets (TTM)

MDLN0.0%

SOLV0.0%

Interest Coverage (TTM)

MDLNN/A

SOLVN/A

Net Debt/EBITDA (TTM)

MDLN0.00x

SOLV0.00x

Beta

MDLN0.94

SOLV0.74

52W Performance

MDLN-11.6%

SOLV20.5%

YTD Performance

MDLN-10.7%

SOLV10.5%

% from 52W High

MDLN-28.7%

SOLV-7.3%

% from 52W Low

MDLN15.1%

SOLV39.9%

Asset Turnover (TTM)

MDLN0.78x

SOLV0.59x

FCF Yield (TTM)

MDLN3.2%

SOLV-0.8%

Earnings Yield (TTM)

MDLN1.5%

SOLV9.5%

Dividend Yield (TTM)

MDLNN/A

SOLVN/A

Rule of 40

MDLN5.2

SOLV-2.3

EV/GP/RG

MDLN0.72

SOLV1.58

Ticker research

View MDLN research View SOLV research

Metric	MDLN Medline Inc	SOLV Solventum Corp
Market & Valuation
Market Cap	$47.63B	$15.12B
Enterprise Value	$57.88B	$20.00B
Price	$36.26	$87.29
P/E Ratio	44.92x	10.55x
P/S Ratio	1.59x	1.82x
EV/Sales	1.93x	2.41x
EV/EBITDA	17.66x	18.02x
P/B Ratio	4.05x	3.12x
P/FCF Ratio	30.81x	N/A
EV/FCF	37.44x	-172.41x
PEG Ratio	3.82x	0.04x
Forward P/E (NTM)	24.12x	12.69x
Forward P/S (NTM)	1.44x	1.77x
Revenue & Growth
Revenue (TTM)	$29.94B	$8.31B
Revenue Growth (YoY)	N/A	-0.9%
Forward Rev Growth	7.8%	3.5%
Profitability
Gross Margin (TTM)	26.2%	54.8%
Operating Margin (TTM)	6.0%	23.9%
EBITDA Margin (TTM)	10.9%	13.4%
Net Margin (TTM)	2.3%	17.3%
FCF Margin (TTM)	5.2%	-1.4%
Net Income (TTM)	$695M	$1.43B
FCF (TTM)	$1.55B	$-116M
EPS (TTM)	$0.81	$8.27
ROE (TTM)	5.5%	29.0%
ROA (TTM)	1.8%	10.1%
ROIC (TTM)	2.6%	14.2%
Financial Health
Cash	$2.33B	$403M
Debt	$12.58B	$5.29B
Net Cash/Debt	$-10.25B	$-4.88B
Current Ratio (TTM)	4.33x	1.02x
Quick Ratio (TTM)	2.61x	0.70x
Debt/Equity (TTM)	1.09x	1.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	0.74
52W Performance	-11.6%	20.5%
YTD Performance	-10.7%	10.5%
% from 52W High	-28.7%	-7.3%
% from 52W Low	15.1%	39.9%
Efficiency & Yields
Asset Turnover (TTM)	0.78x	0.59x
FCF Yield (TTM)	3.2%	-0.8%
Earnings Yield (TTM)	1.5%	9.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.2	-2.3
EV/GP/RG	0.72	1.58
Ticker research	View MDLN research	View SOLV research

Valuation

P/E Ratio

SOLV

10.55x

MDLN

44.92x

P/S Ratio

MDLN

1.59x

SOLV

1.82x

EV/FCF

SOLV

-172.41x

MDLN

37.44x

Growth & revenue

Revenue Growth TTM

SOLV

-0.9%

Forward Revenue Growth

MDLN

7.8%

SOLV

3.5%

Profitability & performance

Gross Margin

SOLV

54.8%

MDLN

26.2%

ROE

SOLV

29.0%

MDLN

5.5%

FCF Yield %

MDLN

3.2%

SOLV

-0.8%

52-Week Performance

SOLV

20.5%

MDLN

-11.6%

Detailed metrics comparison

MDLN

Medline Inc

SOLV

Solventum Corp

Market Cap

MDLN$47.63B

SOLV$15.12B

Enterprise Value

MDLN$57.88B

SOLV$20.00B

Price

MDLN$36.26

SOLV$87.29

P/E Ratio

MDLN44.92x

SOLV10.55x

P/S Ratio

MDLN1.59x

SOLV1.82x

EV/Sales

MDLN1.93x

SOLV2.41x

EV/EBITDA

MDLN17.66x

SOLV18.02x

P/B Ratio

MDLN4.05x

SOLV3.12x

P/FCF Ratio

MDLN30.81x

SOLVN/A

EV/FCF

MDLN37.44x

SOLV-172.41x

PEG Ratio

MDLN3.82x

SOLV0.04x

Forward P/E (NTM)

MDLN24.12x

SOLV12.69x

Forward P/S (NTM)

MDLN1.44x

SOLV1.77x

Revenue (TTM)

MDLN$29.94B

SOLV$8.31B

Revenue Growth (YoY)

MDLNN/A

SOLV-0.9%

Forward Rev Growth

MDLN7.8%

SOLV3.5%

Gross Margin (TTM)

MDLN26.2%

SOLV54.8%

Operating Margin (TTM)

MDLN6.0%

SOLV23.9%

EBITDA Margin (TTM)

MDLN10.9%

SOLV13.4%

Net Margin (TTM)

MDLN2.3%

SOLV17.3%

FCF Margin (TTM)

MDLN5.2%

SOLV-1.4%

Net Income (TTM)

MDLN$695M

SOLV$1.43B

FCF (TTM)

MDLN$1.55B

SOLV$-116M

EPS (TTM)

MDLN$0.81

SOLV$8.27

ROE (TTM)

MDLN5.5%

SOLV29.0%

ROA (TTM)

MDLN1.8%

SOLV10.1%

ROIC (TTM)

MDLN2.6%

SOLV14.2%

Cash

MDLN$2.33B

SOLV$403M

Debt

MDLN$12.58B

SOLV$5.29B

Net Cash/Debt

MDLN$-10.25B

SOLV$-4.88B

Current Ratio (TTM)

MDLN4.33x

SOLV1.02x

Quick Ratio (TTM)

MDLN2.61x

SOLV0.70x

Debt/Equity (TTM)

MDLN1.09x

SOLV1.10x

Debt/Assets (TTM)

MDLN0.0%

SOLV0.0%

Interest Coverage (TTM)

MDLNN/A

SOLVN/A

Net Debt/EBITDA (TTM)

MDLN0.00x

SOLV0.00x

Beta

MDLN0.94

SOLV0.74

52W Performance

MDLN-11.6%

SOLV20.5%

YTD Performance

MDLN-10.7%

SOLV10.5%

% from 52W High

MDLN-28.7%

SOLV-7.3%

% from 52W Low

MDLN15.1%

SOLV39.9%

Asset Turnover (TTM)

MDLN0.78x

SOLV0.59x

FCF Yield (TTM)

MDLN3.2%

SOLV-0.8%

Earnings Yield (TTM)

MDLN1.5%

SOLV9.5%

Dividend Yield (TTM)

MDLNN/A

SOLVN/A

Rule of 40

MDLN5.2

SOLV-2.3

EV/GP/RG

MDLN0.72

SOLV1.58

Ticker research

View MDLN research View SOLV research

Metric	MDLN Medline Inc	SOLV Solventum Corp
Market & Valuation
Market Cap	$47.63B	$15.12B
Enterprise Value	$57.88B	$20.00B
Price	$36.26	$87.29
P/E Ratio	44.92x	10.55x
P/S Ratio	1.59x	1.82x
EV/Sales	1.93x	2.41x
EV/EBITDA	17.66x	18.02x
P/B Ratio	4.05x	3.12x
P/FCF Ratio	30.81x	N/A
EV/FCF	37.44x	-172.41x
PEG Ratio	3.82x	0.04x
Forward P/E (NTM)	24.12x	12.69x
Forward P/S (NTM)	1.44x	1.77x
Revenue & Growth
Revenue (TTM)	$29.94B	$8.31B
Revenue Growth (YoY)	N/A	-0.9%
Forward Rev Growth	7.8%	3.5%
Profitability
Gross Margin (TTM)	26.2%	54.8%
Operating Margin (TTM)	6.0%	23.9%
EBITDA Margin (TTM)	10.9%	13.4%
Net Margin (TTM)	2.3%	17.3%
FCF Margin (TTM)	5.2%	-1.4%
Net Income (TTM)	$695M	$1.43B
FCF (TTM)	$1.55B	$-116M
EPS (TTM)	$0.81	$8.27
ROE (TTM)	5.5%	29.0%
ROA (TTM)	1.8%	10.1%
ROIC (TTM)	2.6%	14.2%
Financial Health
Cash	$2.33B	$403M
Debt	$12.58B	$5.29B
Net Cash/Debt	$-10.25B	$-4.88B
Current Ratio (TTM)	4.33x	1.02x
Quick Ratio (TTM)	2.61x	0.70x
Debt/Equity (TTM)	1.09x	1.10x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.94	0.74
52W Performance	-11.6%	20.5%
YTD Performance	-10.7%	10.5%
% from 52W High	-28.7%	-7.3%
% from 52W Low	15.1%	39.9%
Efficiency & Yields
Asset Turnover (TTM)	0.78x	0.59x
FCF Yield (TTM)	3.2%	-0.8%
Earnings Yield (TTM)	1.5%	9.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5.2	-2.3
EV/GP/RG	0.72	1.58
Ticker research	View MDLN research	View SOLV research